Corpus Luteum Degeneration in Pregnancy: The Luteal-Placental Shift
The corpus luteum (CL) forms from the ruptured follicle after ovulation. It secretes progesterone and estradiol, essential for endometrial maintenance and early pregnancy support.
The Luteal-Placental Shift
- Weeks 1–7: CL is sole progesterone source. Rescue by hCG from implanting blastocyst prevents luteolysis.
- Weeks 7–10: Placenta begins steroidogenesis; dual progesterone source.
- Weeks 10–12: Placenta assumes full progesterone production. CL regresses (luteolysis) via apoptosis and macrophage clearance.
Why Degeneration Is Necessary
- Prevents excessive progesterone (associated with fetal growth restriction, maternal metabolic changes).
- Removes a source of relaxin (cervical ripening) at term-inappropriate time.
- Allows placental autonomy—progesterone synthesis shifts to placental syncytiotrophoblast using maternal LDL cholesterol.
Clinical Correlates
- Luteal phase defect: Inadequate CL progesterone → implantation failure/early loss.
- CL cyst: Persistent cystic CL (>3 cm); usually asymptomatic, resolves by 16–20 weeks. Torsion/rupture rare but painful.
- Progesterone supplementation: Given in ART, recurrent loss, or short cervix; mimics CL support until placental takeover.
The luteal-placental shift is a precisely timed endocrine handoff—critical for pregnancy maintenance.
Genetic Disorders - Related Articles
- Hereditary Ataxias: Genetic Types, Clinical Features, and Diagnosis
- Identifying and Protecting Yourself from Sociopathic Behavior
- Blood Type O: Origins and the ABO Gene—What You Need to Know
- Cystic Fibrosis Carrier Status: Genetics, Risks, and Family Planning
- Genetic Diseases: Over 7,000 Known, Most Without Cures—But Progress Is Accelerating
- Albright's Disease (McCune-Albright Syndrome): Symptoms, Causes & Treatment
- Down Syndrome Prevalence: Understanding Population Risks & Factors
